| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.0M | -5.1% |
| Cost of Revenue | $100K | +0.0% |
| Gross Profit | $10.0M | -20.5% |
| R&D Expense | $200K | +0.0% |
| SG&A Expense | $29.0M | +12.6% |
| Operating Income | -$25.0M | -22.8% |
| Interest Expense | $14K | +0.0% |
| Pre-tax Income | -$23.8M | -17.5% |
| Net Income | -$23.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | -85.4% |
| Accounts Receivable | $457K | -62.0% |
| Current Assets | $5.4M | -80.1% |
| Total Assets | $13.7M | -59.3% |
| Current Liabilities | $6.8M | -9.3% |
| Total Liabilities | $8.9M | +9.4% |
| Stockholders' Equity | $4.8M | -81.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.6M | -24.5% |
| Capital Expenditures | $924K | -61.4% |
| Investing Cash Flow | -$924K | +64.6% |
| Financing Cash Flow | $24.2M | +0.0% |
| Free Cash Flow | -$20.5M | -13.1% |
| -17.5% |
| EPS (Basic) | -$1.04 | -8.3% |